SNEX vs IONS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SNEX · StoneX$54.31 ▲ 1.29%
IONS · Ionis Pharmaceuticals$39.42 ▲ 1.60%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SNEX +34.7%
- IONS -43.3%
Head to head
| Metric | SNEX | IONS |
|---|---|---|
| Price | $54.31 | $39.42 |
| Change today | ▲ 1.29% | ▲ 1.60% |
| Market cap | $6.55B | $6.55B |
| Return, 3 months | -16.1% | -30.8% |
| Return, year to date | +28.5% | -50.2% |
| Return, 1 year | +37.2% | -46.4% |
| P/E (TTM) | 13.0 | -11.3 |
| P/B | 2.3 | 14.9 |
| P/E percentile vs own 5y | 62nd | 81st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +15.4% | -40.7% |
| Net profit growth (YoY) | +101.7% | -192.8% |
| Gross margin | 2.2% | 98.2% |
| Operating margin | 1.7% | -68.0% |
| Net margin | 0.3% | -64.7% |
| Return on equity | 21.2% | -105.5% |
| Analyst target vs. price | +106.2% | +112.8% |
| Analyst buy share | 100% | 90% |
| RSI (14) | 37 | 33 |
| 30-day volatility | 38.8% | 38.0% |
| Max drawdown, 1 year | -43.0% | -55.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IONS is the largest of the group by market value.
- SNEX has returned the most over the past year.
- IONS carries the lowest trailing P/E.
- SNEX is growing revenue fastest.
- SNEX keeps the most profit per dollar of sales.
- IONS has been the calmest stock over the last 30 days.